Asensus Surgical, Inc. (ASXC)
AMEX AMEX Primary Summary
Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates
Asensus Surgical (ASXC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.09 per share a year ago.
Asensus Surgical, Inc. (ASXC) Q2 2024 Earnings Call Transcript
Asensus Surgical, Inc. (NYSE:ASXC ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Mark Klausner - IR, Westwicke Partners Anthony Fernando - President and CEO Shameze Rampertab - CFO Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to Asensus Surgical Incorporated Second Quarter Financial and Operating Results Call. At this time, all lines are in listen-only mode.
Asensus Surgical (ASXC) Announces New Hospital Tie-Up on Senhance
Asensus Surgical (ASXC) announces an agreement with St. Marianna University School of Medicine Yokohama City Seibu Hospital to lease its Senhance Surgical System.
Asensus Surgical, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AAL Avraham A. Levitan Glass Jacobson Investment Advisors LLC | 3,000 | $810 | $1,050 | $240 | 29.63% |
Asensus Surgical, Inc. (ASXC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Asensus Surgical, Inc. ever had a stock split?
Asensus Surgical, Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Anthony Fernando CEO | AMEX Exchange | 04367G103 CUSIP |
| US Country | 207 Employees | - Last Dividend | 12 Dec 2019 Last Split | 12 Nov 1992 IPO Date |
Overview
Asensus Surgical, Inc. is at the forefront of the medical device industry, focusing on the development and commercialization of robotics designed to enhance minimally invasive surgery (MIS). With operations spreading across the United States, Europe, the Middle East, Africa, and Asia, the company aims to revolutionize the way surgical procedures are performed. By digitizing the interface between surgeons and patients, Asensus Surgical facilitates performance-guided surgery, allowing surgeons to achieve improved outcomes for their patients. Originally known as TransEnterix, Inc., the company underwent a name change to Asensus Surgical, Inc. in February 2021, marking a new chapter in its mission to advance surgical technology. Its corporate headquarters are located in Durham, North Carolina.
Products and Services
The product portfolio of Asensus Surgical, Inc. is centered around the Senhance System and accompanying surgical tools and devices, which represent groundbreaking advancements in the field of robotic-assisted surgery:
- Senhance System:
This multi-port robotic surgery system empowers surgeons by providing up to four robotic arms that control various surgical instruments and a camera. Designed specifically for laparoscopic procedures, the Senhance System integrates seamlessly into existing hospital infrastructures, allowing for minimally invasive surgeries with precision and control unheard of with traditional manual techniques.
- Instruments and Other Products:
Asensus Surgical offers a range of specialized surgical instruments compatible with the Senhance System. These include instruments with a small diameter of 3mm and versatile hooks available in both 3mm and 5mm sizes. Additionally, the company provides articulating instruments that enhance the flexibility and reach of the robotic arms during procedures, enabling surgeons to perform complex maneuvers with ease.
- Senhance Ultrasonic System:
An advanced energy device, the Senhance ultrasonic system, is designed for surgical procedures requiring the ligation and division of tissue. It delivers controlled energy, allowing for precise cutting and coagulation, which are critical for minimizing intra-operative blood loss and improving surgical outcomes. This system complements the Senhance System, further extending the capabilities of robotic-assisted surgery.
